CTOs on the Move

Vedanta Biosciences

www.vedantabio.com

 
The trillions of microbes that call us home – the human microbiome – perform critical functions that preserve our health including helping develop our immune system, manufacturing nutrients such as vitamins, and harvesting energy from the diet. Alterations of the human microbiome are increasingly recognized as a key factor in autoimmune, metabolic, infectious and many other diseases. For millions of years, humans have co-evolved with this community of microbes, communicating in an ancient language that holds critical clues about how autoimmune and infectious diseases develop. This language is based on a system of signals that our resident microbes use to successfully ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.vedantabio.com
  • 19 Blackstone Street 3rd Floor
    Cambridge, MA USA 02139
  • Phone: 857.706.1427

Executives

Name Title Contact Details

Funding

Vedanta Biosciences raised $50M on 06/07/2016
Vedanta Biosciences raised $27M on 12/24/2018
Vedanta Biosciences raised $18.5M on 05/13/2019
Vedanta Biosciences raised $16.6M on 09/23/2019
Vedanta Biosciences raised $76.9M on 09/30/2020
Vedanta Biosciences raised $25M on 01/12/2021

Similar Companies

Integrity Laboratories

CollabRx

CollabRx is a clinical decision-support company delivering expert solutions in precision oncology that enable physicians, laboratories, payers, and providers to achieve standardized, evidence-based care and superior clinical outcomes. CollabRx uses information technology to aggregate and contextualize the world`s knowledge on genomics-based medicine with specific insights from the nation`s top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care.

Osel Inc

Osel Inc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Covance Labs

Covance Labs is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

STIMIT

STIMIT`s proprietary technology enables extended local delivery of cancer immunotherapy in the context of tumor resection, the standard of care for most patients with solid tumors. Concentrating and retaining the action of potent immunomodulators locally dramatically improves the efficacy and safety of these compounds relative to administration in solution, whether via intravenous or even intratumoral injection.